Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Hartman ML
Stay informed about the regulatory landscape
2 glules par jour avec un grand verre d'eau au cours des repas
Pancreatitis is an uncommon but serious adverse effect associated with GLP-1 receptor agonists (occurring in approximately 0.10.2% of patients)
Lynparza (olaparib) Disease area(s): Oncology Manufacturer(s): AstraZeneca/Merck 2024 Sales (USD): $4.98 billion Why it sold so well: AstraZenecas Lynparza delivered a strong sales performance in 2024, with product revenues reaching $3.67 billion, marking a 22% increase at constant exchange rates compared to the previous year
US$ 23.66
US$ 20.71
US$ 28.78
US$ 23.93
